Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 2
2018 1
2020 1
2021 2
2022 1
2023 1
2024 2
2025 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Cited In for PMID: 27573428

12 results

Results by year

Filters applied: . Clear all
Page 1
Dinutuximab Beta Versus Naxitamab in the Treatment of Relapsed/Refractory Neuroblastoma in Patients with Stable Disease, Minor Response or Partial Response and Disease in Bone or Bone Marrow: Systematic Review and Matching-Adjusted Indirect Comparison.
Lode HN, Holko P, Wieczorek A, Siebert N, Valteau-Couanet D, Garaventa A, Cañete A, Anderson J, Yaniv I, Ash S, Gray J, Luksch R, Manzitti C, Troschke-Meurer S, Ebeling T, Kawalec P, Śladowska K, Ladenstein RL. Lode HN, et al. Cancers (Basel). 2025 Aug 22;17(17):2723. doi: 10.3390/cancers17172723. Cancers (Basel). 2025. PMID: 40940820 Free PMC article.
International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents.
Casey RT, Hendriks E, Deal C, Waguespack SG, Wiegering V, Redlich A, Akker S, Prasad R, Fassnacht M, Clifton-Bligh R, Amar L, Bornstein S, Canu L, Charmandari E, Chrisoulidou A, Freixes MC, de Krijger R, de Sanctis L, Fojo A, Ghia AJ, Huebner A, Kosmoliaptsis V, Kuhlen M, Raffaelli M, Lussey-Lepoutre C, Marks SD, Nilubol N, Parasiliti-Caprino M, Timmers HHJLM, Zietlow AL, Robledo M, Gimenez-Roqueplo AP, Grossman AB, Taïeb D, Maher ER, Lenders JWM, Eisenhofer G, Jimenez C, Pacak K, Pamporaki C. Casey RT, et al. Nat Rev Endocrinol. 2024 Dec;20(12):729-748. doi: 10.1038/s41574-024-01024-5. Epub 2024 Aug 15. Nat Rev Endocrinol. 2024. PMID: 39147856 Review.
Impact of risk-based therapy on late morbidity and mortality in neuroblastoma survivors: a report from the Childhood Cancer Survivor Study.
Friedman DN, Goodman PJ, Leisenring WM, Diller LR, Cohn SL, Howell RM, Smith SA, Tonorezos ES, Wolden SL, Neglia JP, Ness KK, Gibson TM, Nathan PC, Turcotte LM, Weil BR, Robison LL, Oeffinger KC, Armstrong GT, Sklar CA, Henderson TO. Friedman DN, et al. J Natl Cancer Inst. 2024 Jun 7;116(6):885-894. doi: 10.1093/jnci/djae062. J Natl Cancer Inst. 2024. PMID: 38460547 Free PMC article.
Advancing therapy for neuroblastoma.
Qiu B, Matthay KK. Qiu B, et al. Nat Rev Clin Oncol. 2022 Aug;19(8):515-533. doi: 10.1038/s41571-022-00643-z. Epub 2022 May 25. Nat Rev Clin Oncol. 2022. PMID: 35614230 Review.
Current Consensus on I-131 MIBG Therapy.
Kayano D, Kinuya S. Kayano D, et al. Nucl Med Mol Imaging. 2018 Aug;52(4):254-265. doi: 10.1007/s13139-018-0523-z. Epub 2018 May 3. Nucl Med Mol Imaging. 2018. PMID: 30100938 Free PMC article. Review.
12 results